Latest biotech cuts hit pioneering DNA sequencing company, Verily’s eye-focused joint venture

The moves are the latest in a string of cuts as a three-year slowdown in life sciences continues.
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks